| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |